The Vanderbilt University School of Medicine has established a new award to recognize and support outstanding graduate students who have distinguished themselves through the excellence, significance and scientific rigor of their work.

The Vanderbilt Institute of Chemical Biology (VICB) will hold a Founders’ Celebration mini-symposium on March 28 to acknowledge the contributions of its founders, Lawrence Marnett, PhD, and Ned Porter, PhD, and to celebrate 15-plus years of success as a trans-institutional scientific incubator.

New findings suggest that oxidative stress damages mitochondrial DNA, and they link this damage to a disease state.

Carlos F. Lopez, assistant professor of biochemistry and biomedical informatics, has been appointed as Vanderbilt University's liaison to Oak Ridge National Laboratory.

Communication and collaboration were major themes of the inaugural Research Enterprise Forum sponsored jointly by Vanderbilt University Medical Center (VUMC) and Vanderbilt University School of Medicine (VUSM) Feb. 3 in Light Hall.

Alyssa Hasty, Ph.D., professor of Molecular Physiology and Biophysics, has been named Associate Dean for Faculty Development for Basic Sciences at Vanderbilt University School of Medicine.

More than a decade after the anti-inflammatory drugs Vioxx and Bextra were pulled from the market because of a heightened risk of heart attack and stroke in some patients, COX-2 inhibitors may be on the verge of a comeback, this time as anti-cancer agents.